Literature DB >> 10932083

Celery allergy confirmed by double-blind, placebo-controlled food challenge: a clinical study in 32 subjects with a history of adverse reactions to celery root.

B K Ballmer-Weber1, S Vieths, D Lüttkopf, P Heuschmann, B Wüthrich.   

Abstract

BACKGROUND: Celery root is a frequent cause of food allergy in pollen-sensitized patients. Because of problems in blinding challenges with fresh vegetables and the risk of anaphylactic reactions, no double-blind, placebo-controlled, food challenges (DBPCFCs) with celery have been published so far.
OBJECTIVE: The aim of the study was to confirm the clinical relevance of celery as a food allergen by DBPCFCs and to evaluate current diagnostic procedures in patients with true allergy.
METHODS: DBPCFCs were performed in 32 patients with a history of an allergic reaction to celery. The patients underwent skin prick tests (SPTs) with celery extracts, crude celery, and different pollen extracts. Specific IgE for celery was determined by using the CAP method.
RESULTS: Twenty-two of 32 patients had a positive DBPCFC result. Two patients reacted to placebo, and 8 patients did not respond to the challenge. Of the nonresponders, 4 reacted to an open provocation with celery. The sensitivity of CAP determination for specific IgE (> or =0.7 kU/L) to celery in patients with a positive DBPCFC result was 73%, 48% to 86% for SPTs (> or =3 mm) with commercial extracts, and 96% for prick-to-prick tests with crude celery. The positive predictive value of the SPT and CAP tests was between 87% and 96%, whereas the specificity and negative predictive values were poor.
CONCLUSION: This study confirms the importance of celery as a food allergen for use in DBPCFCs. The SPT and CAP methods proved to be reliable for the diagnosis of a relevant allergy to celery in regard to sensitivity and positive predictive value but not to specificity and negative predictive value.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10932083     DOI: 10.1067/mai.2000.107196

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  21 in total

1.  Food allergy and atopic dermatitis: how are they connected?

Authors:  Annice Heratizadeh; Katja Wichmann; Thomas Werfel
Journal:  Curr Allergy Asthma Rep       Date:  2011-08       Impact factor: 4.806

Review 2.  [Cutaneous symptoms after ingestion of pollen-associated foodstuffs].

Authors:  B K Ballmer-Weber
Journal:  Hautarzt       Date:  2006-02       Impact factor: 0.751

3.  [Food allergy in atopic dermatitis].

Authors:  K Wichmann; A Heratizadeh; T Werfel
Journal:  Hautarzt       Date:  2012-04       Impact factor: 0.751

Review 4.  [Cross-reactive allergen clusters in pollen-associated food allergy].

Authors:  J Kleine-Tebbe; D A Herold
Journal:  Hautarzt       Date:  2003-01-29       Impact factor: 0.751

Review 5.  Food allergy in children.

Authors:  J O Hourihane; P K Smith; S Strobel
Journal:  Indian J Pediatr       Date:  2002-01       Impact factor: 1.967

6.  Panallergens and their impact on the allergic patient.

Authors:  Michael Hauser; Anargyros Roulias; Fátima Ferreira; Matthias Egger
Journal:  Allergy Asthma Clin Immunol       Date:  2010-01-18       Impact factor: 3.406

7.  Epitope Mapping of Allergenic Lipid Transfer Proteins.

Authors:  Clara San Bartolomé; Carmen Oeo-Santos; Pablo San Segundo-Acosta; Rosa Muñoz-Cano; Javier Martínez-Botas; Joan Bartra; Mariona Pascal
Journal:  Methods Mol Biol       Date:  2021

Review 8.  Food Allergies Caused by Allergenic Lipid Transfer Proteins: What Is behind the Geographic Restriction?

Authors:  M J Rial; J Sastre
Journal:  Curr Allergy Asthma Rep       Date:  2018-09-11       Impact factor: 4.806

Review 9.  Adult food allergy.

Authors:  Denise A Moneret-Vautrin; Martine Morisset
Journal:  Curr Allergy Asthma Rep       Date:  2005-01       Impact factor: 4.919

10.  Sensitization prevalence, antibody cross-reactivity and immunogenic peptide profile of Api g 2, the non-specific lipid transfer protein 1 of celery.

Authors:  Gabriele Gadermaier; Michael Hauser; Matthias Egger; Rosetta Ferrara; Peter Briza; Keity Souza Santos; Danila Zennaro; Tamara Girbl; Laurian Zuidmeer-Jongejan; Adriano Mari; Fatima Ferreira
Journal:  PLoS One       Date:  2011-08-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.